Myocardial Infarct Clinical Trials

323 recruitingLast updated: July 25, 2026

There are 323 actively recruiting myocardial infarct clinical trials across 52 countries. Studies span Not Applicable, Phase 4, Phase 3, Phase 2, Early Phase 1, Phase 1. Top locations include Seoul, South Korea, London, United Kingdom, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Myocardial Infarct Trials at a Glance

323 actively recruiting trials for myocardial infarct are listed on ClinicalTrialsFinder across 6 cities in 52 countries. The largest study group is Not Applicable with 119 trials, with the heaviest enrollment activity in Seoul, London, and Beijing. Lead sponsors running myocardial infarct studies include Assistance Publique - Hôpitaux de Paris, National Institute of Cardiovascular Diseases, Pakistan, and Queen Mary University of London.

Browse myocardial infarct trials by phase

Treatments under study

About Myocardial Infarct Clinical Trials

Looking for clinical trials for Myocardial Infarct? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Myocardial Infarct trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Myocardial Infarct clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 323 trials

Recruiting
Not Applicable

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock

Heart FailureCardiogenic ShockAcute Myocardial Infarction (AMI)
Magenta Medical Ltd.10 enrolled8 locationsNCT07293923
Recruiting
Phase 3

Ivabradine in the Acute Management of Cardiogenic Shock

Cardiogenic Shock Post Myocardial Infarction
National Institute of Cardiovascular Diseases, Pakistan200 enrolled1 locationNCT07714746
Recruiting
Not Applicable

Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)

Acute Myocardial Infarction (AMI)ST-segment elevation myocardial infarction (STEMI)Non-ST-Segment Elevation Myocardial Infarction(NSTEMI)
Harbin Medical University2,000 enrolled48 locationsNCT07567625
Recruiting
Not Applicable

The Effect of Virtual Reality Application Diagnosed With Myocardial Infarction

Myocardial Infarction
Yuzuncu Yil University50 enrolled1 locationNCT07696390
Recruiting
Phase 2

A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction

Acute Anterior ST-Segment Elevation Myocardial Infarction
Beijing Sungen Biomedical Technology Co., Ltd210 enrolled1 locationNCT07306182
Recruiting

Noninvasive Artificial Venous Stasis for Reperfusion in STEMI

STEMI - ST Elevation Myocardial Infarction
Firat University500 enrolled2 locationsNCT07689591
Recruiting
Phase 2Phase 3

Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI Study

STEMI - ST Elevation Myocardial Infarction
Oxford University Hospitals NHS Trust60 enrolled1 locationNCT07687576
Recruiting
Phase 2

Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction

Myocardial InfarctionSTEMI (ST Elevation MI)Reperfusion Injury+1 more
Nyrada Pty Ltd300 enrolled7 locationsNCT07362446
Recruiting
Not Applicable

Sixth Generation High-sensitivity Cardiac Troponin T for the Early Rule Out of Myocardial Infarction: a Controlled Before and After Study

Myocardial Infarction
University of Edinburgh19,500 enrolled3 locationsNCT07636642
Recruiting
Not Applicable

Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI)

Myocardial Infarction, AcuteMulti Vessel Coronary Artery DiseaseMulti-Vessel Coronary Artery Stenosis
Chonnam National University Hospital1,014 enrolled1 locationNCT04968808
Recruiting
Phase 4

Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

Dual Antiplatelet TherapyST Elevated Myocardial Infarction
Research Maatschap Cardiologen Rotterdam Zuid1,656 enrolled27 locationsNCT05491200
Recruiting
Not Applicable

Transcultural Digital Solutions in Phase III Cardiac Rehabilitation

Heart FailureMyocardial Infarction
Fondazione Don Carlo Gnocchi ETS306 enrolled6 locationsNCT07252856
Recruiting
Phase 4

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

Acute Coronary SyndromeMyocardial InfarctionCoronary Artery Disease+1 more
Duk-Woo Park, MD3,320 enrolled45 locationsNCT04416581
Recruiting
Phase 1

The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy Participants

Peripheral Arterial DiseaseRecent Myocardial InfarctionRecent Stroke+1 more
Shanghai CureGene Pharmaceutical Co., Ltd.136 enrolled1 locationNCT07619885
Recruiting
Phase 3

Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction

Gastrointestinal BleedingAcute Myocardial Infarction (AMI)
Samsung Medical Center5,000 enrolled1 locationNCT07467213
Recruiting

Diagnostic Accuracy of GPT-4o and Claude for HEART Score Calculation in Chest Pain

Artificial Intelligence (AI)Artificial Intelligence (AI) in DiagnosisEmergency Medicine+1 more
Marmara University Pendik Training and Research Hospital690 enrolled1 locationNCT07626060
Recruiting

Diagnostic Performance of Artificial Intelligence Algorithms in Prediction of Acute Coronary Syndrome Based on White Blood Cell Properties

Acute Coronary SyndromeAngina PectorisSTEMI - ST Elevation Myocardial Infarction+2 more
RobotDreams GmbH3,350 enrolled1 locationNCT06384846
Recruiting

Rapid Microaxial Flow Pump Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock and Persistent Need of Hemodynamic Support

Cardiogenic Shock Post Myocardial Infarction
University Hospital of Cologne115 enrolled1 locationNCT07655479
Recruiting

Registry of Acute Myocardial Infarction

Myocardial Infarction, Acute
Tomsk National Research Medical Center of the Russian Academy of Sciences97,500 enrolled1 locationNCT06252168
Recruiting
Not Applicable

Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI-2 Trial

ST-elevation Myocardial Infarction (STEMI)Primary PCI
Chen Jing6,294 enrolled1 locationNCT07361783